Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference
December 07 2009 - 7:00AM
PR Newswire (US)
CARLSBAD, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Genoptix, Inc.
(NASDAQ: GXDX), a specialized laboratory services provider, today
announced the Company's participation at the Deutsche Bank 2009
MedTools Investor Conference to be held at the Intercontinental
Hotel in Boston, Mass. on December 9-10, 2009. Genoptix's EVP and
COO, Sam Riccitelli, will be in attendance to represent the Company
on Wednesday, December 9, 2009. He will provide an overview of the
Company's specialized diagnostic laboratory services business,
growth strategies and financial performance. About Genoptix, Inc.
Genoptix is a leading specialized laboratory service provider
focused on delivering personalized and comprehensive diagnostic
services to its physician customers, community-based hematologists
and oncologists. On the forefront of personalized diagnostic
services, Genoptix's highly trained group of hematopathologists
utilize sophisticated technology to provide integrated testing and
actionable diagnostic reports. Its diagnostic services are designed
to optimize the care of patients suffering from hematomalignancies,
or cancers of the blood and bone marrow, including leukemia and
lymphoma. Founded in 1999, Genoptix completed its initial public
offering in November 2007 and is headquartered in Carlsbad,
California. For more information, please visit
http://www.genoptix.com/. Forward-Looking Statements This press
release contains forward-looking statements that are subject to
risks and uncertainties that could cause actual results to differ
materially from those set forth in the forward-looking statements.
Genoptix disclaims, however, any intent or obligation to update
these forward-looking statements. DATASOURCE: Genoptix, Inc.
CONTACT: Marcy Graham, Sr. Director, Investor Relations of
Genoptix, Inc., +1-760-930-7150, ; or Sarah Thailing, Principal of
Wordanista, +1-619-994-1895, , for Genoptix, Inc. Web Site:
http://www.genoptix.com/
Copyright